Larimar Therapeutics, Inc. - Common Stock, par value $0.001 per share (LRMR)

Historical Holders from Q2 2020 to Q3 2025

Symbol
LRMR on Nasdaq
CUSIP
517125100
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
85.6M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
85.5M
Holdings value
$275M
% of all portfolios
0.002%
Grand Portfolio weight change
+0%
Number of holders
132
Number of buys
84
Number of sells
-35
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Larimar Therapeutics, Inc. - Common Stock, par value $0.001 per share (LRMR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Flynn James E 35.81% $82.5M 30.7M Deerfield Management Company, L.P. Jul 31, 2025
MILLENNIUM MANAGEMENT LLC 5.8% +3.33% $16M $4.53M 4.97M +39.4% Millennium Management LLC Sep 30, 2025
Opaleye Management Inc. 4.8% -22.8% $16M $615K 4.11M +3.99% Opaleye Management, Inc. Aug 29, 2025
BlackRock, Inc. 4.8% -6% $5.27M -$318K 3.08M -5.7% BlackRock, Inc. Mar 31, 2025
GOLDMAN SACHS GROUP INC 4.1% $4.45M 2.6M THE GOLDMAN SACHS GROUP, INC. Mar 31, 2025

Institutional Holders of Larimar Therapeutics, Inc. - Common Stock, par value $0.001 per share (LRMR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 85.5M $275M +$75.2M $3.23 132
2025 Q2 62.3M $180M +$7.44M $2.89 116
2025 Q1 60.8M $132M -$12.3M $2.15 101
2024 Q4 63.4M $245M -$5.9M $3.87 114
2024 Q3 64.3M $421M -$5.93M $6.55 122
2024 Q2 65.3M $473M +$12.2M $7.25 105
2024 Q1 63.6M $483M +$183M $7.59 104
2023 Q4 11.5K $52.2K $4.55 1
2023 Q3 38.7M $153M -$3.46M $3.95 63
2023 Q2 39M $120M -$3.68M $3.13 64
2023 Q1 38.5M $174M +$996K $4.53 68
2022 Q4 38.8M $160M +$976K $4.13 47
2022 Q3 38.5M $123M +$77.8M $3.20 49
2022 Q2 14.4M $28.2M -$2.24M $1.96 33
2022 Q1 15.3M $61.8M -$5.13M $4.05 40
2021 Q4 14.6M $157M +$903K $10.79 46
2021 Q3 14.4M $166M -$883K $11.53 50
2021 Q2 14.5M $143M -$4.48M $9.82 43
2021 Q1 14.1M $206M -$8.48M $14.61 54
2020 Q4 13.8M $295M +$5.24M $21.41 40
2020 Q3 13.6M $207M +$10.4M $15.17 37
2020 Q2 12.9M $166M +$166M $12.85 33